Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Dobric

Showing results (11-20 of 21) with videos related to

Pageof 3
Sort By:
Journal of Pharmacological Sciences|November 23, 2006
An experimental model of prolonged esophagitis with sphincter failure in the rat and the therapeutic potential of gastric pentadecapeptide BPC 157Igor Petrovic, Ivan Dobric, Petar Drvis, et al.
Biomedicines|November 27, 2021
Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in RatsMladen Japjec, Katarina Horvat Pavlov, Andreja Petrovic, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Acute Compartment Syndrome and Intra-Abdominal Hypertension, Decompression, Current Pharmacotherapy, and Stable Gastric Pentadecapeptide BPC 157 SolutionPredrag Sikiric, Sven Seiwerth, Anita Skrtic, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A ReviewDanijel Matek, Irena Matek, Mladen Japjec, et al.
Journal of Pharmacological Sciences|April 25, 2007
Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157Ivan Dobric, Petar Drvis, Igor Petrovic, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis FunctionPredrag Sikiric, Slaven Gojkovic, Ivan Krezic, et al.
Frontiers in Pharmacology|July 16, 2021
Stable Gastric Pentadecapeptide BPC 157 and Wound HealingSven Seiwerth, Marija Milavic, Jaksa Vukojevic, et al.
Biomedicines|December 23, 2022
Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart MuscleMario Staresinic, Mladen Japjec, Hrvoje Vranes, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Stable Gastric Pentadecapeptide BPC 157 Therapy: Effect on Reperfusion Following Maintained Intra-Abdominal Hypertension (Grade III and IV) in RatsMarijan Tepes, Ivan Krezic, Hrvoje Vranes, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
From Selye's and Szabo's Cysteamine-Duodenal Ulcer in Rats to Dopamine in the Stomach: Therapy Significance and PossibilitiesPredrag Sikiric, Alenka Boban Blagaic, Ivan Krezic, et al.
Pageof 3

Showing results (11-20 of 21) with videos related to

Sort By:
Pageof 3
Journal of Pharmacological Sciences|November 23, 2006
An experimental model of prolonged esophagitis with sphincter failure in the rat and the therapeutic potential of gastric pentadecapeptide BPC 157Igor Petrovic, Ivan Dobric, Petar Drvis, et al.
Biomedicines|November 27, 2021
Stable Gastric Pentadecapeptide BPC 157 as a Therapy for the Disable Myotendinous Junctions in RatsMladen Japjec, Katarina Horvat Pavlov, Andreja Petrovic, et al.
Pharmaceuticals (Basel, Switzerland)|June 27, 2025
Acute Compartment Syndrome and Intra-Abdominal Hypertension, Decompression, Current Pharmacotherapy, and Stable Gastric Pentadecapeptide BPC 157 SolutionPredrag Sikiric, Sven Seiwerth, Anita Skrtic, et al.
Pharmaceuticals (Basel, Switzerland)|February 27, 2026
Tendon, Ligament, and Muscle Injury, Osteotendinous, Myotendinous, and Muscle-to-Bone Junction Therapy Perspectives with Growth Factors and Stable Gastric Pentadecapeptide BPC 157-A ReviewDanijel Matek, Irena Matek, Mladen Japjec, et al.
Journal of Pharmacological Sciences|April 25, 2007
Prolonged esophagitis after primary dysfunction of the pyloric sphincter in the rat and therapeutic potential of the gastric pentadecapeptide BPC 157Ivan Dobric, Petar Drvis, Igor Petrovic, et al.
Pharmaceuticals (Basel, Switzerland)|May 27, 2023
Stable Gastric Pentadecapeptide BPC 157 May Recover Brain-Gut Axis and Gut-Brain Axis FunctionPredrag Sikiric, Slaven Gojkovic, Ivan Krezic, et al.
Frontiers in Pharmacology|July 16, 2021
Stable Gastric Pentadecapeptide BPC 157 and Wound HealingSven Seiwerth, Marija Milavic, Jaksa Vukojevic, et al.
Biomedicines|December 23, 2022
Stable Gastric Pentadecapeptide BPC 157 and Striated, Smooth, and Heart MuscleMario Staresinic, Mladen Japjec, Hrvoje Vranes, et al.
Pharmaceuticals (Basel, Switzerland)|November 25, 2023
Stable Gastric Pentadecapeptide BPC 157 Therapy: Effect on Reperfusion Following Maintained Intra-Abdominal Hypertension (Grade III and IV) in RatsMarijan Tepes, Ivan Krezic, Hrvoje Vranes, et al.
Pharmaceuticals (Basel, Switzerland)|December 23, 2023
From Selye's and Szabo's Cysteamine-Duodenal Ulcer in Rats to Dopamine in the Stomach: Therapy Significance and PossibilitiesPredrag Sikiric, Alenka Boban Blagaic, Ivan Krezic, et al.
Pageof 3